Iverson Conrado Bezerra

Iverson Conrado Bezerra

Auto-generated profile, based on publicly available information

Iverson Conrado Bezerra

Keizo Asami Institute, iLIKA, Federal University of Pernambuco, Recife, 50670-901, Brazil; Graduate Program in Biology Applied to Health, PPGBAS, Federal University of Pernambuco, Recife, 50670-901, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2025 in Journal of Neurochemistry
Verified
Journal Article
Open access
IBIverson Conrado Bezerra
Iverson Conrado Bezerra
ESEmily Raphaely Souza dos Santos
Emily Raphaely Souza dos Santos
KNKatarine G. Aurista Do Nascimento
Katarine G. Aurista Do Nascimento
ASArtur José da Silva
Artur José da Silva
JFJosivan Barbosa de Farias
Josivan Barbosa de Farias
PGPriscila Gubert
Priscila Gubert
Alzheimer's disease (AD) is the most common form of dementia, posing significant challenges to cognitive, emotional, social, and financial well‐being. The biochemical and molecular pathways associated with AD are complex, making it difficult to study and simulate in patients or through in vitro research. Thus, animal models play a crucial role in investigating the development and progression of AD. One widely used model in neuroscience studies is the free‐living nematode Caenorhabditis elegans (C. elegans). The development of transgenic animals has allowed for the construction of the dvls2 (CL2006) C. elegans strain, which constitutively expresses the amyloid beta (Aβ) peptide. This study conducted a proteomic analysis on the dvls2 (CL2006) strain. Also, a cross‐species comparative analysis was performed using microarray data from AD patients to identify genes with ontology in the dvls2 (CL2006). A total of 543 proteins were found to be differentially regulated in the dvls2 (CL2006) strain. Furthermore, in the analysis of the human datasets, 397 upregulated and 767 downregulated genes were identified. The differentially expressed genes (DEGs) were analyzed in Ortholist to identify their orthologs in C. elegans. Then, the orthologous genes in the dvls2 (CL2006) model were compared to the proteomic data, resulting in the identification of 29 upregulated and 24 downregulated proteins (DEPs). Functional enrichment analysis of DEPs revealed terms related to pyruvate, glucose, and glutamate metabolism, in addition to binding activities to unfolded proteins and ligases, highlighting the upregulation of chaperone and ubiquitination‐associated proteins. Protein–protein network (PPI) was performed for the human DEGs and DEPs of dvls2 (CL2006). Topological analyses of the networks were performed, revealing the following C. elegans hub proteins: EEF‐2, ALH‐13, ENOL‐1, RPL‐2, TPI‐1, CTS‐1, RPL‐9, RPL‐23, CCT‐1, and RPS‐8. eEF‐2 was identified as a key regulator of the human AD PPI and dvls2 (CL2006). Modules were analyzed in the networks, and the presence of key regulators was identified. This study provides the first proteomic characterization of the AD model dvls2 (CL2006) and a cross‐species comparative analysis with data from AD individuals, supporting the use of dvls2 (CL2006) in AD studies. image

22 January 2024 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
SMSandra Regina Nunes de Andrade Medeiros
Sandra Regina Nunes de Andrade Medeiros
IBIverson Conrado Bezerra
Iverson Conrado Bezerra
ASArtur José da Silva
Artur José da Silva
LPLucas Aleixo Leal Pedroza
Lucas Aleixo Leal Pedroza
RMRegildo Max Gomes Martins
Regildo Max Gomes Martins
AFAntonio Alves de Melo Filho
Antonio Alves de Melo Filho

1 November 2024 in The Natural Products Journal
Verified
Journal Article
Closed access
PDF file
MVMaria Cristina Vasconcellos
Maria Cristina Vasconcellos
IBIverson Conrado Bezerra
Iverson Conrado Bezerra
DMDaniel dos Santos Macedo
Daniel dos Santos Macedo
BFBeatriz Luci Fernandes
Beatriz Luci Fernandes
PGPriscila Gubert
Priscila Gubert
Plants produce promising chemicals called secondary metabolites in response to stress, which protect against oxidative damage in both plants and humans. Reactive oxygen species (ROS) levels combined with an imbalance in the antioxidant responses can trigger oxidative stress that is related to many conditions such as Alzheimer's disease, diabetes, and cancer. One way to counteract or avoid the stress excess is by flavonoid administration, a class of plant metabolites with a consistent antioxidant action and the ability to inactivate the free radical excess. The mechanisms, as well as the benefits and toxicity of antioxidant products, can be tested in alternative animal models. The mechanisms, as well as the benefits and toxicity of antioxidant products, can be tested in alternative animal models. In this review, we explored how Caenorhabditis elegans, a nematode with high genetic similarity to human genes and the antioxidant response pathway conserved, can be considered an attractive model organism for testing flavonoid compounds. Here, we emphasize the crucial results regarding C. elegans and the flavonoid quercetin, focusing on oxidative stress and aging investigations. Also, this review highlights the quercetin benefits in C. elegans lifespan, healthspan, neurodegeneration, and impacts on insulin/IGF-1 signaling (IIS).

27 December 2025 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
IBIverson Conrado Bezerra
Iverson Conrado Bezerra
JVJéssika de Oliveira Viana
Jéssika de Oliveira Viana
JBJocelin Santa Rita Bisneto
Jocelin Santa Rita Bisneto
GCGabriel Gomes Cavalcante
Gabriel Gomes Cavalcante
JLJoão Gabriel Barbosa de Luna
João Gabriel Barbosa de Luna
PGPriscila Gubert
Priscila Gubert

23 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
IBIverson Conrado Bezerra
Iverson Conrado Bezerra
MVMaria Luiza de Lima Vitorino
Maria Luiza de Lima Vitorino
JFJosivan Barbosa de Farias
Josivan Barbosa de Farias
MMMaria Gabriela Arruda de Medeiros
Maria Gabriela Arruda de Medeiros
RSRoberto Afonso da Silva
Roberto Afonso da Silva
PGPriscila Gubert
Priscila Gubert
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease in the elderly population, characterized by a wide variety of motor and non-motor symptoms. Its complex biochemical and molecular mechanisms make it challenging to study PD directly in patients or to replicate it in vitro, underscoring the need for careful model characterization to advance translational research. The free-living nematode Caenorhabditis elegans has been widely used in neuroscience studies. Technological advancements enabled the development of transgenic strains that mimic aspects of neurodegenerative diseases, such as the OW13 strain [ grk-1 (ok1239) X; pkIs2386 IV ( unc-54 p::alpha-synuclein::YFP + unc-119 (+))], which expresses human α-synuclein in body wall muscle cells in a sensitized G-protein coupled receptor kinase-deficient background. This study conducted an exploratory proteomic analysis of the OW13 strain. A cross-species comparative analysis using post-mortem substantia nigra proteomics from PD individuals identified a convergent signature of 76 conserved C. elegans proteins, corresponding to 70 human orthologs, derived from the 373 DAPs. Among these conserved candidates, 68 proteins were upregulated, and 8 were downregulated. Functional enrichment linked these DAPs to the tricarboxylic acid cycle, mitochondrial function, and protein quality control, suggesting that α-synuclein aggregation triggers a broad proteostatic and bioenergetic remodeling resembling PD pathophysiology. This first proteomic and cross-species characterization of the OW13 strain strongly supports C. elegans as a robust PD model.